|
Other Stroke Treatment - Medical
Citations 391-400 of 1151 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Deletion of Angiotensin II Type 2 Receptor Attenuates Protective Effects of Bone Marrow Stromal Cell Treatment on Ischemia–Reperfusion Brain Injury in Mice
- Jun Iwanami, Masaki Mogi, Jian-Mei Li, Kana Tsukuda, Li-Juan Min, Akiko Sakata, Teppei Fujita, Masaru Iwai, and Masatsugu Horiuchi
Stroke published July 10, 2008, doi:10.1161/STROKEAHA.107.513275
[Abstract]
- Articles
Factors That Influence the Stroke Care Team's Effectiveness in Reducing the Length of Hospital Stay
- Loes M.T. Schouten, Marlies E.J.L. Hulscher, Reinier Akkermans, Jannes J.E. van Everdingen, Richard P.T.M. Grol, and Robbert Huijsman
Stroke published July 10, 2008, doi:10.1161/STROKEAHA.107.510537
[Abstract]
- Articles
Escalating Levels of Access to In-Hospital Care and Stroke Mortality
- Gustavo Saposnik, Jiming Fang, Martin O'Donnell, Vladimir Hachinski, Moira K. Kapral, Michael D. Hill on behalf of the Investigators of the Registry of the Canadian Stroke Network (RCSN) for the Stroke Outcome Research Canada (SORCan) Working Group
Stroke published July 10, 2008, doi:10.1161/STROKEAHA.107.507145
[Abstract]
- Original Contributions
Temporary Pretreatment With the Angiotensin II Type 1 Receptor Blocker, Valsartan, Prevents Ischemic Brain Damage Through an Increase in Capillary Density
- Jian-Mei Li, Masaki Mogi, Jun Iwanami, Li-Juan Min, Kana Tsukuda, Akiko Sakata, Teppei Fujita, Masaru Iwai, and Masatsugu Horiuchi
Stroke 2008;39:2029-2036; published online before print as doi:10.1161/STROKEAHA.107.503458
[Abstract]
[Full text]
- Original Contributions
Influence of Socioeconomic Status and Gender on Stroke Treatment and Diagnostics
- Jasmin Arrich, Marcus Müllner, Wolfgang Lalouschek, Stefan Greisenegger, Richard Crevenna, and Harald Herkner
Stroke 2008;39:2066-2072; published online before print as doi:10.1161/STROKEAHA.107.506147
[Abstract]
[Full text]
- Research Letters
Effect of Statins on Intracerebral Hemorrhage Outcome and Recurrence
- Emilie FitzMaurice, Lauren Wendell, Ryan Snider, Kristin Schwab, Rishi Chanderraj, Cathrine Kinnecom, Kaveer Nandigam, Natalia S. Rost, Anand Viswanathan, Jonathan Rosand, Steven M. Greenberg, and Eric E. Smith
Stroke 2008;39:2151-2154; published online before print as doi:10.1161/STROKEAHA.107.508861
[Abstract]
[Full text]
- Comments, Opinions, and Reviews
Endothelial Progenitor Cell Research in Stroke: A Potential Shift in Pathophysiological and Therapeutical Concepts
- Rob P.W. Rouhl, Robert J. van Oostenbrugge, Jan Damoiseaux, Jan-Willem Cohen Tervaert, and Jan Lodder
Stroke 2008;39:2158-2165; published online before print as doi:10.1161/STROKEAHA.107.507251
[Abstract]
[Full text]
- Emerging Therapies
The PREVAIL Trial and Low-Molecular-Weight Heparin for Prevention of Venous Thromboembolism
- Keith W. Muir
Stroke 2008;39:2174-2176; published online before print as doi:10.1161/STROKEAHA.107.509588
[Full text]
- Emerging Therapies
Management of Hyperglycemia in Acute Stroke: How, When, and for Whom?
- Michael T. McCormick, Keith W. Muir, Christopher S. Gray, and Matthew R. Walters
Stroke 2008;39:2177-2185; published online before print as doi:10.1161/STROKEAHA.107.496646
[Full text]
- Cochrane Corner
Puerarin for Acute Ischemic Stroke
- Yan Tan, Ming Liu, and Bo Wu
Stroke 2008;39:2188; published online before print as doi:10.1161/STROKEAHA.107.512228
[Full text]
|
|
